PLK2 and B-cell non-Hodgkin lymphoma: It has been identified that Polo-like kinase 2 (PLK2) methylation-dependent transcriptional silencing occurs in B cell lymphomas, 100% of Burkitt lymphoma (BL) cell lines and a similarly high proportion of primary BL.